alanine has been researched along with terbutaline in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cryer, PE; Wiethop, BV | 2 |
Cryer, PE; Saleh, TY | 1 |
Bosak, A; Gazić, I; Kovarik, Z; Vinković, V | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
3 trial(s) available for alanine and terbutaline
Article | Year |
---|---|
Glycemic actions of alanine and terbutaline in IDDM.
Topics: Administration, Oral; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Humans; Injections, Subcutaneous; Insulin; Kinetics; Lactates; Random Allocation; Reference Values; Terbutaline | 1993 |
Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Hypoglycemia; Injections, Subcutaneous; Insulin; Lactates; Pancreatic Polypeptide; Terbutaline; Time Factors | 1993 |
Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.
Topics: Adrenergic beta-Agonists; Adult; Alanine; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Terbutaline; Treatment Outcome | 1997 |
2 other study(ies) available for alanine and terbutaline
Article | Year |
---|---|
Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Topics: Acetylcholinesterase; Alanine; Amino Acid Substitution; Amino Acids; Animals; Asparagine; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Glutamine; Isoleucine; Leucine; Mice; Mutagenesis, Site-Directed; Phenylalanine; Recombinant Proteins; Stereoisomerism; Terbutaline; Tyrosine | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |